ASBMT Clinical Affairs Committee developed the first Clinical Standards for Hematopoietic Cell Transplantation.
Parent organization International Society for Hematotherapy and Graft Engineering (ISHAGE) formed. (Currently named International Society Cell & Gene Therapy [ISCT].)
Parent organization American Society for Blood and Marrow Transplantation (ASBMT) formed. (Currently named American Society for Transplantation and Cellular Therapy [ASTCT].)
Regulatory Affairs Committee of ISHAGE developed first draft of laboratory standards for Hematopoietic Cell Collection and Processing.
ASBMT Clinical Standards for Hematopoietic Cell Transplantation and ISHAGE laboratory Standards for Hematopoietic Cell Collection and Processing merged into a single document.
North American Task Force (NATF) concluded that FACT Standards were of sufficiently high quality to serve as a template for the other organizations involved in this field.
Co-founded by ASBMT and ISCT, the Foundation for the Accreditation of Hematopoietic Cell Therapy (FAHCT) was formed for the purpose of:
First edition of FAHCT Standards for Hematopoietic
Progenitor Cell Collection, Processing &
Transplantation published.
Inspection and Accreditation
program began.
First cell therapy transplant
programs awarded FAHCT
accreditation.
FAHCT Standards adopted by JACIE (Joint Accreditation Committee EBMT-ISCT).
FAHCT and NetCord partnered to develop international standards for cord blood collection, processing, testing, banking, selection, and release.
Name changed to the Foundation for the Accreditation of Cellular Therapy (FACT) to encompass, in addition to hematopoietic cell products and therapies, new and exciting therapies such as those using mesenchymal stem cells, dendritric cells, targeted lymphocytes, genetically modified cells, pancreatic islets, and others.
Second Edition of FACT Cellular Therapy Standards published. Cord Blood Bank Inspection and Accreditation program began.
FACT celebrated its 10th anniversary. Third Edition of Cellular Therapy Standards developed and published jointly by FACT and JACIE. Third Edition of Cord Blood Standards developed and published jointly by FACT and NetCord.
FACT committee structure established to lead the organization’s strategic initiatives. FACT accreditation added to methodology to determine the U.S. News & World report rankings of transplant centers for the "America's Best Hospitals" and "America's Best Children's Hospitals" lists.
Educational efforts expanded to include online webinars and tutorials. Fourth Edition of FACT-JACIE Cellular Therapy Standards published.
Fourth Edition of NetCord-FACT Cord Blood Standards published.
Fifth Edition of FACT-JACIE Cellular Therapy Standards published. FACTWeb online accreditation portal launched. Accreditation of laboratories performing more-than-minimal manipulation began. FACT accredited first cell therapy programs in Brazil and Asia.
Fifth Edition of NetCord-FACT Cord Blood Standards published. New Task Forces launched – Clinical Outcomes, Data Management, and Payer Relations. FACT Consulting Services piloted to assist transplant centers. FACT accredited first cord blood banks in Greece and Hong Kong.
FACT accredited first cord blood bank in Brazil. FACT accredited first private cord blood bank in the United States.
Sixth Edition of FACT-JACIE Cellular Therapy Standards published. First Edition of FACT Common Standards for Cellular Therapies published. FACT accredited first cord blood banks in Saudi Arabia and Turkey. FACT Consulting Services officially launched.
FACT celebrated its 20th anniversary. FACT began formally reviewing clinical outcomes. Sixth Edition of NetCord-FACT Cord Blood Standards published. FACT accredited first cell therapy program in Mexico. FACT accredited first cord blood banks in India and Cyprus.
First Edition of FACT Standards for Immune Effector Cells published. FACT and Center for International Blood and Marrow Transplant Research (CIBMTR) began collaborative data audit program. FACT accredited first cord blood bank in Portugal.
Seventh Edition of FACT-JACIE Cellular Therapy Standards published. FACT and the Sociedade Brasileira de Transplante de Medula Óssea (SBTMO) announced formal partnership to develop joint FACT-SBTMO Cellular Therapy Accreditation Program in Brazil. New FACT accreditation portal launched.
Second Edition of FACT Common Standards for Cellular Therapies published. Seventh Edition NetCord-FACT International Standards for Cord Blood Collection, Banking, and Release for Administration published. FACT-SBTMO joint accreditation program launched in Brazil. First FACT-JACIE Stepwise Accreditation inspections conducted in Latin America.
FACT responds to global COVID-19 pandemic to protect the safety of its volunteer inspectors and program personnel by implementing virtual inspections. FACT publishes joint statement with the ASTCT, CIBMTR, ISCT, and EBMT stating that acts of racism are inexcusable and that as a community, we are committed to critical initiatives to move toward equality in transplantation, the cellular and gene therapy workforce, and in access to lifesaving therapies.
FACT celebrated its 25th anniversary. Eighth Edition of FACT-JACIE International Standards for Hematopoietic Cellular Therapy Product Collection, Processing, and Administration is published. First program to complete Step One of the FACT-JACIE Stepwise Accreditation program awarded Certificate of Completion. FACT completes transition from 25-year relationship with the University of Nebraska Medical Center to become an independent entity enabling the organization to better respond to progress and advancements in the rapidly changing field of cellular therapy.
Promoting quality patient care and
laboratory practice in cellular therapies
Principal
Members:
© 2024 The Foundation for the Accreditation of Cellular Therapy.
All Rights Reserved.
